MedTrace Logo

Non Invasive Cancer Test (NICT): a Proof of Principle Study.

NCT03019471 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-10-07

No results posted yet for this study

Summary

The investigators aim to collect tumor DNA out of blood of cancer patients. If this is successful this could lead to the development of a cancer test in blood in the future, which is less invasive than current diagnostic methods.

Conditions

  • Neoplasmata

Interventions

GENETIC

Isolation of tumor DNA

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Christine C. De Die-Smulders, Prof. dr. · Clinical Geneticist in MUMC+

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03019471 on ClinicalTrials.gov